Propofol - Drug Shortage Information

Public shortage context is available across 17 visible exact NDC pages for this generic family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Current and historical shortage references are available across related Propofol presentations from multiple manufacturers.

  • 6 current shortage context pages.
  • 11 historical shortage context pages.
  • 6 manufacturers represented.

Related research paths

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug NameNDC 11ManufacturerShortage Context
propofol 10 mg / mL Injection 20 mLPRN Watchlist
NDC 80830-1188-07 | 10 Vial | Amneal Pharmaceuticals Private Limited
80830-1188-07Amneal Pharmaceuticals Private LimitedCurrent shortage context
propofol 10 mg / mL Injection 50 mLPRN Watchlist
NDC 80830-2364-08 | 20 Vial | Amneal Pharmaceuticals Private Limited
80830-2364-08Amneal Pharmaceuticals Private LimitedCurrent shortage context
propofol 10 mg / mL Injection 100 mLPRN Watchlist
NDC 80830-2365-07 | 10 Vial | Amneal Pharmaceuticals Private Limited
80830-2365-07Amneal Pharmaceuticals Private LimitedCurrent shortage context
Propofol 10 mg / mL Injection 20 mLPRN Watchlist
NDC 00641-6194-10 | 10 Vial, Single-Use | Hikma Pharmaceuticals USA Inc.
00641-6194-10Hikma Pharmaceuticals USA Inc.Current shortage context
Propofol 10 mg / mL Injection 50 mLPRN Watchlist
NDC 00641-6195-20 | 20 Vial, Single-Use | Hikma Pharmaceuticals USA Inc.
00641-6195-20Hikma Pharmaceuticals USA Inc.Current shortage context
Propofol 10 mg / mL Injection 100 mLPRN Watchlist
NDC 00641-6196-10 | 10 Vial, Single-Use | Hikma Pharmaceuticals USA Inc.
00641-6196-10Hikma Pharmaceuticals USA Inc.Current shortage context
propofol 10 mg / mL Injection 20 mLPRN Watchlist
NDC 25021-0608-20 | 25 Vial | Sagent Pharmaceuticals
25021-0608-20Sagent PharmaceuticalsHistorical shortage context
propofol 10 mg / mL Injection 50 mLPRN Watchlist
NDC 25021-0608-50 | 20 Vial | Sagent Pharmaceuticals
25021-0608-50Sagent PharmaceuticalsHistorical shortage context
propofol 10 mg / mL Injection 100 mLPRN Watchlist
NDC 25021-0608-51 | 10 Vial | Sagent Pharmaceuticals
25021-0608-51Sagent PharmaceuticalsHistorical shortage context
Propofol 10 mg / mL Injection 50 mL (Diprivan)PRN Watchlist
NDC 63323-0269-50 | 20 Vial | Fresenius Kabi USA, LLC
63323-0269-50Fresenius Kabi USA, LLCHistorical shortage context
Propofol 10 mg / mL Injection 100 mL (Diprivan)PRN Watchlist
NDC 63323-0269-65 | 10 Vial | Fresenius Kabi USA, LLC
63323-0269-65Fresenius Kabi USA, LLCHistorical shortage context
Propofol 10 mg / mL Injection 100 mLPRN Watchlist
NDC 00409-4699-24 | 10 Vial | Hospira, Inc.
00409-4699-24Hospira, Inc.Historical shortage context
Propofol 10 mg / mL Injection 50 mLPRN Watchlist
NDC 00409-4699-33 | 20 Vial | Hospira, Inc.
00409-4699-33Hospira, Inc.Historical shortage context
Propofol 10 mg / mL Injection 20 mLPRN Watchlist
NDC 00409-6010-25 | 25 Vial | Hospira, Inc.
00409-6010-25Hospira, Inc.Historical shortage context
Propofol 10 mg / mL Injection 20 mLPRN Watchlist
NDC 00069-0209-10 | 10 Vial | Pfizer Laboratories Div Pfizer Inc
00069-0209-10Pfizer Laboratories Div Pfizer IncHistorical shortage context
Propofol 10 mg / mL Injection 50 mLPRN Watchlist
NDC 00069-0234-20 | 20 Vial | Pfizer Laboratories Div Pfizer Inc
00069-0234-20Pfizer Laboratories Div Pfizer IncHistorical shortage context
Propofol 10 mg / mL Injection 100 mLPRN Watchlist
NDC 00069-0248-10 | 10 Vial | Pfizer Laboratories Div Pfizer Inc
00069-0248-10Pfizer Laboratories Div Pfizer IncHistorical shortage context

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.